LogicBio Therapeutics, Inc(NASDAQ:LOGC) 
LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic eff...
Website: http://www.logicbio.com
Founded: 2014
Full Time Employees: 39 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.70
H 6.83
L 6.30
C 6.46
V 494,467
10EMA 6.46
20EMA 6.46
60EMA 6.46
120EMA 6.46
250EMA 6.46